| Name | Safeway Pharmacy #1535 |
|---|---|
| Organization Name | Safeway Inc |
| Location | 1515 E Elliot Rd, Tempe, Arizona 85284 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (480) 755-1944 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
"Patients often experience a great deal of pain if their cancer spreads to the bone," explained Andre Konski, M.D., M.B.A., M.A., F.A.C.R., director of clinical research in the radiation oncology department at Fox Chase Cancer Center and lead author of the paper on the Radiation Therapy Oncology Group study (RTOG 97-14).
With the State Department's reassurance to aid groups on Tuesday that they "will not face prosecution if they are forced to pay bribes to al-Shabab or if militants divert some food supplies," organizations still have "the problem of gaining access to famine victims and ensuring the safety of their personnel, a number of whom have been murdered by the militants," a Washington Post editorial says.
CTI BioPharma Corp. announced today that it has completed recruitment in the PERSIST-1 pivotal Phase 3 clinical trial of pacritinib, a novel oral JAK2/FLT3 inhibitor that is being evaluated for the treatment of myelofibrosis.
Researchers at The Wistar Institute have described the role of mitochondrial fission factor (MFF) in controlling survival of cancer cells, suggesting the protein could represent a promising therapeutic target. They also found that expression of MFF is regulated by Myc, a ubiquitous mediator of cell proliferation that contributes to development of many cancer types.
› Verified 5 days ago
| NPI Number | 1528097573 |
| Organization Name | SAFEWAY INC |
| Doing Business As | SAFEWAY PHARMACY #1535 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 1515 E Elliot Rd, Tempe, AZ 85284 |
| Phone Number | 480-755-1944 |
News Archive
"Patients often experience a great deal of pain if their cancer spreads to the bone," explained Andre Konski, M.D., M.B.A., M.A., F.A.C.R., director of clinical research in the radiation oncology department at Fox Chase Cancer Center and lead author of the paper on the Radiation Therapy Oncology Group study (RTOG 97-14).
With the State Department's reassurance to aid groups on Tuesday that they "will not face prosecution if they are forced to pay bribes to al-Shabab or if militants divert some food supplies," organizations still have "the problem of gaining access to famine victims and ensuring the safety of their personnel, a number of whom have been murdered by the militants," a Washington Post editorial says.
CTI BioPharma Corp. announced today that it has completed recruitment in the PERSIST-1 pivotal Phase 3 clinical trial of pacritinib, a novel oral JAK2/FLT3 inhibitor that is being evaluated for the treatment of myelofibrosis.
Researchers at The Wistar Institute have described the role of mitochondrial fission factor (MFF) in controlling survival of cancer cells, suggesting the protein could represent a promising therapeutic target. They also found that expression of MFF is regulated by Myc, a ubiquitous mediator of cell proliferation that contributes to development of many cancer types.
› Verified 5 days ago
News Archive
"Patients often experience a great deal of pain if their cancer spreads to the bone," explained Andre Konski, M.D., M.B.A., M.A., F.A.C.R., director of clinical research in the radiation oncology department at Fox Chase Cancer Center and lead author of the paper on the Radiation Therapy Oncology Group study (RTOG 97-14).
With the State Department's reassurance to aid groups on Tuesday that they "will not face prosecution if they are forced to pay bribes to al-Shabab or if militants divert some food supplies," organizations still have "the problem of gaining access to famine victims and ensuring the safety of their personnel, a number of whom have been murdered by the militants," a Washington Post editorial says.
CTI BioPharma Corp. announced today that it has completed recruitment in the PERSIST-1 pivotal Phase 3 clinical trial of pacritinib, a novel oral JAK2/FLT3 inhibitor that is being evaluated for the treatment of myelofibrosis.
Researchers at The Wistar Institute have described the role of mitochondrial fission factor (MFF) in controlling survival of cancer cells, suggesting the protein could represent a promising therapeutic target. They also found that expression of MFF is regulated by Myc, a ubiquitous mediator of cell proliferation that contributes to development of many cancer types.
› Verified 5 days ago
Nielsen And Cyment, Inc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 2403 W Huntington Dr, Tempe, Arizona 85282 Phone: (480) 675-9122 | |
Preferred Homecare Type: Durable Medical Equipment & Medical Supplies Supplier Location: 3280 S Country Club Way, Tempe, Arizona 85282 Phone: (480) 505-0038 | |
Cvs Pharmacy #09205 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 802 S Mill Ave, Tempe, Arizona 85281 Phone: (480) 966-6271 | |
Cvs Pharmacy #05950 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 855 E Elliot Rd, Tempe, Arizona 85284 Phone: (480) 456-3602 | |
Cvs Pharmacy #07078 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 3303 S Rural Rd, Tempe, Arizona 85282 Phone: (480) 345-6328 |